Cas:19064-64-3 3,6-Dichloro-4-methylpyridazine manufacturer & supplier

We serve Chemical Name:3,6-Dichloro-4-methylpyridazine CAS:19064-64-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,6-Dichloro-4-methylpyridazine

Chemical Name:3,6-Dichloro-4-methylpyridazine
CAS.NO:19064-64-3
Synonyms:3,6-Dichlor-4-methyl-pyridazin;EINECS 242-794-3;MFCD00006465;3,6-Dichloro-4-methyl-1,2-diazine;3,6-dichloro-4-methyl-pyridazine;Pyridazine, 3,6-dichloro-4-methyl-;4-methyl-3,6-dichloropyridazine;3,6-Dichloro-4-methylpyridazine;3,6-dichloro-5-methylpyridazine;Pyridazine,3,6-dichloro-4-methyl;3,6-Dichloro-4-methylpyridazin
Molecular Formula:C5H4Cl2N2
Molecular Weight:163.005
HS Code:2933990090

Physical and Chemical Properties:
Melting point:86-88 °C(lit.)
Boiling point:272.1±0.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.551
PSA:25.78000
Exact Mass:161.975159
LogP:1.36

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 3,6-Dichlor-4-methyl-pyridazin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,6-Dichloro-4-methylpyridazin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,6-dichloro-4-methyl-pyridazine Use and application,3,6-Dichloro-4-methylpyridazin technical grade,usp/ep/jp grade.


Related News: After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million. 2,2-dihydroxy-24-tridecaoxidane manufacturers The incredible selectivity of enzyme catalysts consequently simplifies workflows by generating fewer by-products and reducing impurities to markedly decrease the total number of synthetic steps required. (3-carbonochloridoyl-2-oxochromen-7-yl) acetate suppliers Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. Ethanone, 1-(2,3-dichlorophenyl)-2-fluoro-2-(1H-1,2,4-triazol-1-yl)- vendor & factory.